These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26364162)

  • 41. The impact of lifestyle on Barrett's Esophagus: A precursor to esophageal adenocarcinoma.
    Navab F; Nathanson BH; Desilets DJ
    Cancer Epidemiol; 2015 Dec; 39(6):885-91. PubMed ID: 26519660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.
    Buas MF; He Q; Johnson LG; Onstad L; Levine DM; Thrift AP; Gharahkhani P; Palles C; Lagergren J; Fitzgerald RC; Ye W; Caldas C; Bird NC; Shaheen NJ; Bernstein L; Gammon MD; Wu AH; Hardie LJ; Pharoah PD; Liu G; Iyer P; Corley DA; Risch HA; Chow WH; Prenen H; Chegwidden L; Love S; Attwood S; Moayyedi P; MacDonald D; Harrison R; Watson P; Barr H; deCaestecker J; Tomlinson I; Jankowski J; Whiteman DC; MacGregor S; Vaughan TL; Madeleine MM
    Gut; 2017 Oct; 66(10):1739-1747. PubMed ID: 27486097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma.
    Becker J; May A; Gerges C; Anders M; Veits L; Weise K; Czamara D; Lyros O; Manner H; Terheggen G; Venerito M; Noder T; Mayershofer R; Hofer JH; Karch HW; Ahlbrand CJ; Arras M; Hofer S; Mangold E; Heilmann-Heimbach S; Heinrichs SK; Hess T; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Müller-Myhsok B; Ott K; Schmidt T; Whiteman DC; Vaughan TL; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
    Cancer Med; 2015 Nov; 4(11):1700-4. PubMed ID: 26383589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Ekiz F; Ormeci N; Coban S; Karabulut HG; Aktas B; Tukun A; Tuncali T; Yüksel O; Alkış N
    Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of selected risk factors in Barrett's esophagus development].
    Kiciński P; Mokrowiecka A; Czkwianianc E; Kolasa-Kicińska M; Wozniakowska-Gesicka T; Małecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):390-4. PubMed ID: 19606681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
    Bani-Hani K; Martin IG; Hardie LJ; Mapstone N; Briggs JA; Forman D; Wild CP
    J Natl Cancer Inst; 2000 Aug; 92(16):1316-21. PubMed ID: 10944553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TP53 mutations in malignant and premalignant Barrett's esophagus.
    Dolan K; Walker SJ; Gosney J; Field JK; Sutton R
    Dis Esophagus; 2003; 16(2):83-9. PubMed ID: 12823203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
    Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ
    Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Barrett's esophagus in relatives by endoscopic screening.
    Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
    Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level.
    Schröder J; Chegwidden L; Maj C; Gehlen J; Speller J; Böhmer AC; Borisov O; Hess T; Kreuser N; Venerito M; Alakus H; May A; Gerges C; Schmidt T; Thieme R; Heider D; Hillmer AM; Reingruber J; Lyros O; Dietrich A; Hoffmeister A; Mehdorn M; Lordick F; Stocker G; Hohaus M; Reim D; Kandler J; Müller M; Ebigbo A; Fuchs C; Bruns CJ; Hölscher AH; Lang H; Grimminger PP; Dakkak D; Vashist Y; May S; Görg S; Franke A; Ellinghaus D; Galavotti S; Veits L; Weismüller J; Dommermuth J; Benner U; Rösch T; Messmann H; Schumacher B; Neuhaus H; Schmidt C; Wissinowski TT; Nöthen MM; ; ; ; Dong J; Ong JS; Buas MF; Thrift AP; Vaughan TL; Tomlinson I; Whiteman DC; Fitzgerald RC; Jankowski J; Vieth M; Mayr A; Gharahkhani P; MacGregor S; Gockel I; Palles C; Schumacher J
    Gut; 2023 Apr; 72(4):612-623. PubMed ID: 35882562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.
    Petrick JL; Li N; Anderson LA; Bernstein L; Corley DA; El Serag HB; Hardikar S; Liao LM; Liu G; Murray LJ; Rubenstein JH; Schneider JL; Shaheen NJ; Thrift AP; van den Brandt PA; Vaughan TL; Whiteman DC; Wu AH; Zhao WK; Gammon MD; Cook MB
    Cancer; 2019 Dec; 125(23):4210-4223. PubMed ID: 31490550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.